These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20147170)

  • 1. Construction of fusion proteins for transductional targeting.
    Kawakami Y; Curiel DT
    Cold Spring Harb Protoc; 2009 May; 2009(5):pdb.prot5218. PubMed ID: 20147170
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
    Cristiano RJ; Roth JA
    Cancer Gene Ther; 1996; 3(1):4-10. PubMed ID: 8785711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pVAX1 plasmid vector-mediated gene transfer of soluble TRAIL suppresses human hepatocellular carcinoma growth in nude mice.
    Zhang Y; Ma CH; Liu H; Zhang XM; Sun WS
    Acta Biochim Pol; 2007; 54(2):307-13. PubMed ID: 17546204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of adenovirus vectors for transcriptional targeting.
    Kawakami Y; Curiel DT
    Cold Spring Harb Protoc; 2009 May; 2009(5):pdb.prot5219. PubMed ID: 20147171
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery.
    Watkins SJ; Mesyanzhinov VV; Kurochkina LP; Hawkins RE
    Gene Ther; 1997 Oct; 4(10):1004-12. PubMed ID: 9415305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor.
    Fominaya J; Uherek C; Wels W
    Gene Ther; 1998 Apr; 5(4):521-30. PubMed ID: 9614577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral cell targeting vectors.
    Buchholz CJ; Stitz J; Cichutek K
    Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential.
    Hemminki A; Wang M; Hakkarainen T; Desmond RA; Wahlfors J; Curiel DT
    Cancer Gene Ther; 2003 Aug; 10(8):583-8. PubMed ID: 12872139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vector retargeting for cancer gene therapy.
    Wei W; Xue JL; Tian L
    Ai Zheng; 2009 Jan; 28(1):86-90. PubMed ID: 19448427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of retroviral vectors through protease-substrate interactions.
    Nilson BH; Morling FJ; Cosset FL; Russell SJ
    Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
    Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
    Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor induces changes of interaction between epidermal growth factor receptor and actin in intact cells.
    Song W; Xuan H; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):754-60. PubMed ID: 18685792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral or non-viral angiogenesis gene transfer-New answers to old questions.
    Nikol S
    Cardiovasc Res; 2007 Feb; 73(3):443-5. PubMed ID: 17196566
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor-mediated gene delivery employing lectin-binding specificity.
    Batra RK; Wang-Johanning F; Wagner E; Garver RI; Curiel DT
    Gene Ther; 1994 Jul; 1(4):255-60. PubMed ID: 7584089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-assisted traffic engineering for nonviral gene therapy.
    Vázquez E; Ferrer-Miralles N; Villaverde A
    Drug Discov Today; 2008 Dec; 13(23-24):1067-74. PubMed ID: 18801457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).
    Pokorna D; Cerovska N; Smahel M; Moravec T; Ludvikova V; Mackova J; Synkova H; Duskova M; Hozak P; Veleminsky J
    Oncol Rep; 2005 Oct; 14(4):1045-53. PubMed ID: 16142370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-mediated DNA condensation for non-viral gene therapy.
    Saccardo P; Villaverde A; González-Montalbán N
    Biotechnol Adv; 2009; 27(4):432-8. PubMed ID: 19341789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.